Kcnn2 Blockade Reverses Learning Deficits in a Mouse Model of Fetal Alcohol Spectrum Disorders
Overview
Authors
Affiliations
Learning disabilities are hallmarks of congenital conditions caused by prenatal exposure to harmful agents. These include fetal alcohol spectrum disorders (FASDs) with a wide range of cognitive deficiencies, including impaired motor skill development. Although these effects have been well characterized, the molecular effects that bring about these behavioral consequences remain to be determined. We previously found that the acute molecular responses to alcohol in the embryonic brain are stochastic, varying among neural progenitor cells. However, the pathophysiological consequences stemming from these heterogeneous responses remain unknown. Here we show that acute responses to alcohol in progenitor cells altered gene expression in their descendant neurons. Among the altered genes, an increase of the calcium-activated potassium channel Kcnn2 in the motor cortex correlated with motor learning deficits in a mouse model of FASD. Pharmacologic blockade of Kcnn2 improves these learning deficits, suggesting Kcnn2 blockers as a new intervention for learning disabilities in FASD.
Identification of a Hippocampus-to-Zona Incerta Projection involved in Motor Learning.
Zhang Z, Wang B, Peng Y, Xu Y, Li C, Ning Y Adv Sci (Weinh). 2024; 11(33):e2307185.
PMID: 38958448 PMC: 11434110. DOI: 10.1002/advs.202307185.
Exercise reduces physical alterations in a rat model of fetal alcohol spectrum disorders.
Vargas-Foitzick R, Garcia-Ordenes B, Iratchet D, Acuna A, Alcayaga S, Fernandez C Biol Res. 2024; 57(1):41.
PMID: 38907274 PMC: 11193177. DOI: 10.1186/s40659-024-00520-2.
Effects of prenatal alcohol exposure on the olfactory system development.
Imamura F Front Neural Circuits. 2024; 18:1408187.
PMID: 38818309 PMC: 11138157. DOI: 10.3389/fncir.2024.1408187.
Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders.
Hwang H, Yamashita S, Matsumoto Y, Ito M, Edwards A, Sasaki J Mol Psychiatry. 2024; 29(11):3364-3380.
PMID: 38734844 PMC: 11541007. DOI: 10.1038/s41380-024-02586-6.
Andreu-Fernandez V, Maida N, Marquina M, Mirahi A, Garcia-Algar O, Pichini S Biomedicines. 2024; 12(3).
PMID: 38540110 PMC: 10967977. DOI: 10.3390/biomedicines12030496.